Sofgen Pharma S.A. (PRCWF) SEC Filings — 2025
15 SEC filings for Sofgen Pharma S.A. (PRCWF) in 2025.
Filings
- Sofgen Pharma S.A. 6-K Filing — 6-K · Dec 5, 2025
- Procaps Group, S.A. 6-K Filing — 6-K · Nov 19, 2025
- Procaps Delisted from Nasdaq, Shifts to OTC Expert Market — 20-F · Sep 3, 2025
- Procaps Group CEO Departs — 6-K · Aug 1, 2025
- Procaps Group Appoints New Directors to Board and Committees — 6-K · Jul 14, 2025
- Procaps Group Appoints Two New Directors to Board — 6-K · May 13, 2025
- Procaps Group Announces Private Share Offering — 6-K · Apr 14, 2025
- Procaps Group Raises $130M, Restructures Debt — 6-K · Apr 9, 2025
- Procaps Group Shareholders Approve All Matters at Extraordinary Meeting — 6-K · Mar 25, 2025
- Procaps Group Sets Shareholder Meeting for March 24 — 6-K · Mar 6, 2025
- Procaps Group Schedules Extraordinary Shareholder Meeting — 6-K · Feb 19, 2025
- Procaps Appoints Interim Co-CEOs Amid CEO Departure — 6-K · Feb 3, 2025
- Procaps Group Director Jose Minski Resigns — 6-K · Jan 21, 2025
- Procaps Group Appoints New Director and Audit Committee Member — 6-K · Jan 16, 2025
- Procaps Group Faces Nasdaq Delinquency Over Financial Filings — 6-K · Jan 3, 2025